CDKN2A Unclassified Variants in Familial Malignant Melanoma: Combining Functional and Computational Approaches for Their Assessment

Maria Chiara Scaini, Giovanni Minervini, Lisa Elefanti, Paola Ghiorzo, Lorenza Pastorino, Silvia Tognazzo, Simona Agata, Monica Quaggio, Daniela Zullato, Giovanna Bianchi-Scarrà, Marco Montagna, Emma D'Andrea, Chiara Menin, Silvio C E Tosatto

Research output: Contribution to journalArticle

Abstract

CDKN2A codes for two oncosuppressors by alternative splicing of two first exons: p16INK4a and p14ARF. Germline mutations are found in about 40% of melanoma-prone families, and most of them are missense mutations mainly affecting p16INK4a. A growing number of p16INK4a variants of uncertain significance (VUS) are being identified but, unless their pathogenic role can be demonstrated, they cannot be used for identification of carriers at risk. Predicting the effect of these VUS by either a "standard" in silico approach, or functional tests alone, is rather difficult. Here, we report a protocol for the assessment of any p16INK4a VUS, which combines experimental and computational tools in an integrated approach. We analyzed p16INK4a VUS from melanoma patients as well as variants derived through permutation of conserved p16INK4a amino acids. Variants were expressed in a p16INK4a-null cell line (U2-OS) and tested for their ability to block proliferation. In parallel, these VUS underwent in silico prediction analysis and molecular dynamics simulations. Evaluation of in silico and functional data disclosed a high agreement for 15/16 missense mutations, suggesting that this approach could represent a pilot study for the definition of a protocol applicable to VUS in general, involved in other diseases, as well.

Original languageEnglish
Pages (from-to)828-840
Number of pages13
JournalHuman Mutation
Volume35
Issue number7
DOIs
Publication statusPublished - 2014

Keywords

  • CDKN2A
  • Familial melanoma
  • P16INK4a
  • Variants of uncertain significance
  • VUS

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Medicine(all)

Fingerprint Dive into the research topics of 'CDKN2A Unclassified Variants in Familial Malignant Melanoma: Combining Functional and Computational Approaches for Their Assessment'. Together they form a unique fingerprint.

  • Cite this

    Scaini, M. C., Minervini, G., Elefanti, L., Ghiorzo, P., Pastorino, L., Tognazzo, S., Agata, S., Quaggio, M., Zullato, D., Bianchi-Scarrà, G., Montagna, M., D'Andrea, E., Menin, C., & Tosatto, S. C. E. (2014). CDKN2A Unclassified Variants in Familial Malignant Melanoma: Combining Functional and Computational Approaches for Their Assessment. Human Mutation, 35(7), 828-840. https://doi.org/10.1002/humu.22550